Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Oncogenesis|July 31, 2020
The identification of nuclear αvβ3 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actionsChen Seraya-Bareket, Avivit Weisz, Elena Shinderman-Maman, et al.Molecular Oncology|March 2, 2024
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancerAdi Alfandari, Dotan Moskovich, Avivit Weisz, et al.Journal of the American Heart Association|October 30, 2018
Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE RegistryBehnood Bikdeli, José Luis Lobo, David Jiménez, et al.Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.Oncotarget|April 15, 2015
Low thyroid hormone levels improve survival in murine model for ocular melanomaIdo Didi Fabian, Mordechai Rosner, Ina Fabian, et al.Cancer Letters|November 22, 2020
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancerDotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.Clinical Lymphoma, Myeloma & Leukemia|July 22, 2018
Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot StudyAvi Leader, Noam Benyamini, Anat Gafter-Gvili, et al.Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot StudyAvi Leader, Anat Gafter-Gvili, Noam Benyamini, et al.Acta Haematologica|September 12, 2024
Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective StudyAdrian Duek, Alexandra Tzinman, Kira Maziuk, et al.Plos One|February 15, 2017
Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and PalestiniansGeffen Kleinstern, Rania Abu Seir, Riki Perlman, et al.Pageof 8